文献速递乳腺乳腺X线MR

非典型导管增生与平坦上皮不典型的影像特征及多学科管理考量:当前文献综述

Imaging Characteristics of and Multidisciplinary Management Considerations for Atypical Ductal Hyperplasia and Flat Epithelial Atypia: Review of Current Literature.
PubMed 文献 · Radiographics · 2023-01-01

综述总结乳腺高危病变中平坦上皮不典型(FEA)与非典型导管增生(ADH)的影像特征及多学科管理。FEA进展恶变率较低,部分指南推荐对选择病例以观察替代常规切除;ADH升级为恶变的风险最高,多数协会指南仍推荐手术切除,但近期文献提示完全切除、局限无坏死或显著不典型、钼靶小簇钙化或MRI无强化的ADH或可观察。

要点

  • FEA进展恶变率相对较低,部分指南推荐对选择病例(病灶小且活检完全切除、无乳腺癌史或基因突变或合并ADH等危险因素)以观察替代常规切除。
  • ADH在所有高危病变中升级为恶变的风险最高,多数协会指南仍推荐手术切除。
  • 近期文献提示活检完全切除、局限(少于2或3个灶)无坏死或显著不典型、钼靶小簇钙化或MRI无强化的ADH或可考虑观察。

核心结论

  • FEA和ADH的管理应基于多学科方法,综合考虑患者、影像、临床和病理因素;FEA在 select 病例可观察,ADH多数指南仍推荐手术切除,但部分近期文献提示特定影像和病理特征者可考虑观察。

研究设计与样本

  • 综述当前文献,总结乳腺高危病变(FEA和ADH)的影像特征及多学科管理考量。

关键影像表现/征象

  • FEA和ADH是经皮活检标本中常见的高危病变,良性但历史上因潜在升级为恶性而接受手术切除。
  • ADH在钼靶上可表现为小簇钙化,MRI上可无强化。

诊断标准与关键数值

  • FEA观察的合理条件:目标病灶小且活检完全切除,无乳腺癌史、基因突变或合并ADH等潜在危险因素。
  • ADH可考虑观察的条件:活检完全切除、局限(少于2或3个灶)无坏死或显著不典型、钼靶小簇钙化、MRI无强化。

临床应用与阅片要点

  • 对FEA,部分指南推荐在 select 病例(病灶小且完全切除、无危险因素)以观察替代常规切除。
  • 对ADH,多数协会指南仍推荐手术切除;近期文献提示完全切除、局限无坏死或显著不典型、钼靶小簇钙化或MRI无强化者或可考虑观察。
  • 管理决策应基于多学科方法,综合考虑患者、影像、临床和病理因素。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

High-risk lesions of the breast are frequently encountered in percutaneous biopsy specimens. While benign, these lesions have historically undergone surgical excision due to their potential to be upgraded to malignancy. However, there is emerging evidence that a tailored management approach should be considered to reduce overtreatment of these lesions. Flat epithelial atypia (FEA) and atypical ductal hyperplasia (ADH) are two of the most commonly encountered high-risk lesions. FEA has been shown to have a relatively low rate of progression to malignancy, and some guidelines are now recommending observation over routine excision in select cases. Selective observation may be reasonable in cases where the target lesion is small and completely removed at biopsy and when there are no underlying risk factors, such as a history of breast cancer or genetic mutation or concurrent ADH. ADH has the highest potential upgrade rate to malignancy of all the high-risk lesions. Most society guidelines continue to recommend surgical excision of this lesion. More recently, some literature suggests that ADH lesions that appear completely removed at biopsy, involve limited foci (less than two or three) with no necrosis or significant atypia, manifest as a small group of mammographic calcifications, or demonstrate no enhancement at MRI may be reasonable for observation. Ultimately, management of all high-risk lesions must be based on a multidisciplinary approach that considers all patient, radiologic, clinical, and histopathologic factors. ©RSNA, 2023 Quiz questions for this article are available in the supplemental material.

来源:Radiographics,查看原文。版权归原作者所有。

引用

  1. Harper LK, Carnahan MB, Bhatt AA, et al. Imaging Characteristics of and Multidisciplinary Management Considerations for Atypical Ductal Hyperplasia and Flat Epithelial Atypia: Review of Current Literature. Radiographics. 2023. PMID: 37768862. doi:10.1148/rg.230016

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。